Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Open-label Trial in Healthy Volunteers to Evaluate the Exposure of Aramchol From Two Different Single Doses of an Aramchol Meglumine Tablet

NCT07251712 is registered in ClinicalTrials.gov with Galmed Pharmaceuticals Ltd as lead sponsor.

NCT NCT07251712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07251712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Open-label Trial in Healthy Volunteers to Evaluate the Exposure of Aramchol From Two Different Single Doses of an Aramchol Meglumine Tablet
Lead sponsor
Galmed Pharmaceuticals Ltd
Phase
Phase 1
Overall status
Recruiting
Start date
December 25, 2025
Completion date
October 10, 2026
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy